Last reviewed · How we verify

NCT07049380

Post-Operative Analgesic Effect of Tramadol and Nalbuphine in Smoker and Non-Smoker Patients in LC

Active, enrolled Last updated 3 July 2025
What this trial tests

trial testing Comparative cross sectional in Laparocele in 132 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
17 March 2025
Primary endpoint
1 August 2025
28 February 2026

Quick facts

Lead sponsorSuperior University
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment132
Start date17 March 2025
Primary completion1 August 2025
Estimated completion28 February 2026
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Superior University

Who can join

30 and older, any sex, with Laparocele. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to compare pain severity and analgesic requirements between smokers and nonsmokers following laparoscopic cholecystectomy, evaluating the efficacy of two analgesics, tramadol and nalbuphine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Laparocele

Currently open trials in the same condition.

Other Superior University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07049380.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing